Back to News
Market Impact: 0.3
Envoy Medical Consensus Price Target Increased by 899.99% to $22.10
Source: Nasdaq
Analyst EstimatesAnalyst InsightsHealthcare & Biotech
The average one-year price target for Envoy Medical (NASDAQCM:COCH) was revised to $22.10 per share, up 899.99% from the prior $2.21 estimate dated October 20, 2026. The figures are aggregate analyst targets; the article provides no share-price reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.55
Ticker Sentiment
COCH0.70
More News
- Marvell Technology could plunge on latest multibillion-dollar acquisition
- UOB shares hit four-month low as Q3 profit misses analyst estimates
- Palantir is dropping on earnings. Wall Street analysts remain bullish
- Roku vp, cao Matthew Banks sells $86,906 in shares
- Midterm elections could jolt stocks if Democrats sweep Congress
- Apple and Palantir shares slide in premarket trading following post-bell earnings
From AllMind Research
- AllMind Platform Feature Updates - Fall 2026
- AI Credit Covenant Monitoring: From Clause to Review
- AI-Led Expert Interviews vs. Transcript Libraries
- Weekly Update: Sector Analysis, Improvements on Research Data, and Performance Enhancements
- How to Automate Equity Research Workflows: A Control-First Guide